ArticleScandinavian journal of public health2026
COVID-19 vaccination coverage and the effect on regional disparities in morbidity and mortality among older people in Sweden, 2021-2023.
Article in Scandinavian journal of public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsThe COVID-19 pandemic had substantial impacts on mortality and morbidity, even after the rollout of vaccinations. These impacts however, varied considerably across regions. We examined regional disparities in COVID-19 mortality and hospitalizations among older people in Sweden from January 2021 to August 2023 and assessed the role of vaccination coverage in shaping these disparities.
methodsUsing full-population data on people in Sweden born in 1955 or earlier, we created a nested case-control study. Conditional logistic regressions with county fixed effects were estimated across three periods of vaccination rollout (Doses 1-2, 3-4, and 5-6). County fixed effects were compared across models with and without vaccination adjustment. Further, the benefits of vaccination coverage corresponding to the most successful regions were evaluated with potential impact fractions (PIFs).
resultsAcross counties, the final shares of vaccinated individuals ranged from 94% to 98% for Doses 1 and 2, 90% to 96% for Dose 3, 80% to 91% for Dose 4, 65% to 83% for Dose 5, and 13% to 47% for Dose 6. In models without vaccination adjustments, COVID-19 mortality ranged from -56% to +75% relative to an average county, and hospitalizations from -45% to +51%. Vaccination adjustment had little impact on the disparities. Overall PIFs were 8% to 11% for mortality and 7% to 8% for hospitalizations, with greater PIFs in urban counties.
conclusions
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.